Get started
Author

Elliasu Yakubu Salifu

Observed names: Elliasu Salifu, Elliasu Salifu Yakubu, Elliasu Y. Salifu, Elliasu Yakubu, Salifu, Elliasu Y.
ORCID: 0000-0001-8713-5001
Observed ORCID: 0000-0001-8713-5001
OpenAlex ID: A5069023191
Discovery of Potential KRAS‐SOS1 Inhibitors from South African Natural Compounds: An In silico Approach
2023 · Abdul Rashid Issahaku, Elliasu Y. Salifu, et al. · ChemistrySelect · 51
PDF
Adapting a nurse-led primary care initiative to cardiovascular disease control in Ghana: a qualitative study
2020 · Leah A. Haykin, Jordan A. Francke, et al. · BMC Public Health · 24
PDF
CF3‐Pyridinyl Substitution on Antimalarial Therapeutics: Probing Differential Ligand Binding and Dynamical Inhibitory Effects of a Novel Triazolopyrimidine‐Based Inhibitor on Plasmodium falciparum Dihydroorotate Dehydrogenase
2019 · Clement Agoni, Elliasu Y. Salifu, et al. · Chemistry & Biodiversity · 18
Highlighting the mechanistic role of Olutasidenib (FT-2102) in the selective inhibition of mutated isocitrate dehydrogenase 1 (mIDH1) in cancer therapy
2021 · Elliasu Y. Salifu, Clement Agoni, et al. · Informatics in Medicine Unlocked · 16
PDF
Evaluating the Therapeutic Potential of Curcumin and Synthetic Derivatives: A Computational Approach to Anti-Obesity Treatments
2024 · Marakiya T. Moetlediwa, Babalwa U. Jack, et al. · International Journal of Molecular Sciences · 15
Multi-functional pH-responsive and biomimetic chitosan-based nanoplexes for targeted delivery of ciprofloxacin against bacterial sepsis
2024 · Eman A. Ismail, Calvin A. Omolo, et al. · International Journal of Biological Macromolecules · 15
Integrating Bioinformatics Strategies in Cancer Immunotherapy: Current and Future Perspectives
2020 · Houda N. Washah, Elliasu Y. Salifu, et al. · Combinatorial Chemistry & High Throughput Screening · 12
Halting ionic shuttle to disrupt the synthetic machinery—Structural and molecular insights into the inhibitory roles of Bedaquiline towards Mycobacterium tuberculosis ATP synthase in the treatment of tuberculosis
2019 · Elliasu Y. Salifu, Clement Agoni, et al. · Journal of Cellular Biochemistry · 12
Dual-Target Mycobacterium tuberculosis Inhibition: Insights into the Molecular Mechanism of Antifolate Drugs
2023 · Pritika Ramharack, Elliasu Y. Salifu, et al. · International Journal of Molecular Sciences · 11
PDF
Inside the cracked kernel: establishing the molecular basis of AMG510 and MRTX849 in destabilising KRASG12C mutant switch I and II in cancer treatment
2022 · Abdul Rashid Issahaku, Elliasu Y. Salifu, et al. · Journal of Biomolecular Structure and Dynamics · 11
Impact of compound mutations I1171N + F1174I and I1171N + L1198H on the structure of ALK in NSCLC pathogenesis: atomistic insights
2022 · Elliasu Y. Salifu, Issahaku A. Rashid, et al. · Journal of Biomolecular Structure and Dynamics · 11
In silico identification of potential inhibitors of acyl carrier protein reductase and acetyl CoA carboxylase of Plasmodium falciparum in antimalarial therapy
2023 · Elliasu Y. Salifu, James Abugri, et al. · Frontiers in Drug Discovery · 10
PDF
Triple Mycobacterial ATP-synthase mutations impedes Bedaquiline binding: Atomistic and structural perspectives
2020 · Elliasu Y. Salifu, Clement Agoni, et al. · Computational Biology and Chemistry · 9
Molecular modelling of SdiA protein by selected flavonoid and terpenes compounds to attenuate virulence in Klebsiella pneumoniae
2022 · Idowu Jesulayomi Adeosun, Itumeleng Baloyi, et al. · Journal of Biomolecular Structure and Dynamics · 8
Prioritizing the Catalytic Gatekeepers through Pan- Inhibitory Mechanism of Entrectinib against ALK, ROS1 and TRKA Tyrosine Kinases
2022 · Elliasu Y. Salifu, Abdul Rashid Issahaku, et al. · Cell Biochemistry and Biophysics · 7
The Unusual Architecture of RNA-Dependent RNA Polymerase (RdRp)’s Catalytic Chamber Provides a Potential Strategy for Combination Therapy against COVID-19
2023 · Kamel Metwally, Nader E. Abo-Dya, et al. · Molecules · 6
PDF
Molecular Dynamic Investigation of H5N1 Influenza Virus Dual H274Y-I222K Mutation Resistance to Peramivir
2022 · Ndumiso M. Buthelezi, Sphamandla E. Mtambo, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 4
PDF
Dual‐Inhibition of Human N‐Myristoyltransferase Subtypes Halts Common Cold Pathogenesis: Atomistic Perspectives from the Case of IMP‐1088**
2021 · Clement Agoni, Elliasu Y. Salifu, et al. · Chemistry & Biodiversity · 4
The Dual-Targeting Activity of the Metabolite Substrate of Para-amino Salicyclic Acid in the Mycobacterial Folate Pathway: Atomistic and Structural Perspectives
2020 · Clement Agoni, Pritika Ramharack, et al. · The Protein Journal · 4
Identification of Enhanced Cyclooxygenase-2 (COX-2) Inhibitors Beyond Curcumin Through Virtual Screening to Target Inflammation-Related Metabolic Complications
2026 · Marakiya T. Moetlediwa, Rudzani Ramashia, et al. · International Journal of Molecular Sciences · 3
PDF
Unraveling the Dual Inhibitory Mechanism of Compound 22ac: A Molecular Dynamics Investigation into ERK1 and ERK5 Inhibition in Cancer
2024 · Elliasu Y. Salifu, Mbuso A. Faya, et al. · Computation · 3
PDF
Deciphering the canonical blockade of activated Hageman factor (FXIIa) by benzamidine in the coagulation cascade: A thorough dynamical perspective
2019 · Elliasu Y. Salifu, Clement Agoni, et al. · Chemical Biology & Drug Design · 3
Halting aberrant DNA methylation via in silico Identification of potent inhibitors of DNMT3B enzyme: Atomistic insights
2023 · Lusanda M. Mtetwa, Elliasu Y. Salifu, et al. · Computational Biology and Chemistry · 2
Disrupting the characteristic twist motion; tailored in silico approach towards the design of plasmepsin inhibitors
2022 · Ransford Oduro Kumi, Elliasu Salifu Yakubu, et al. · Informatics in Medicine Unlocked · 1
PDF
The Antimycobacterial Activity, Toxicity and Chemical Composition of South African Propolis
2026 · Nyiko F. Mzimba, Efficient N. Ncube, et al. · Chemistry & Biodiversity
PDF
Works count: 33
Citation count: 260
H-index: 11
I10-index: 12
Year
Topic
Type